Dana-Farber Cancer Institute

This is your central portal for breaking news, the latest research and important updates from Dana-Farber Cancer Institute. Bookmark this page and check back often for updates.

In the Journals

Breastfeeding may reduce risk for ovarian cancer

April 2, 2020
Breastfeeding appeared to be associated with reduced risk for overall ovarian cancer and for the high-grade serous subtype, according to results of a…
In the Journals

Interleukin-1 beta inhibition improves hemoglobin levels, reduces anemia incidence

March 24, 2020
Inflammation inhibition through the interleukin-1 beta/interleukin-6 signaling pathway reduced incidence of anemia and improved hemoglobin levels…

12 medical centers form brain tumor research collaborative

March 22, 2020
Twelve institutions across the United States and Canada formed a collaborative designed to
Meeting News

Neoadjuvant nivolumab with or without ipilimumab induces response in oral cavity cancer

March 6, 2020
Neoadjuvant nivolumab with or without ipilimumab appeared effective and safe for patients with resectable oral cavity cancer, according to results of…
FDA News

FDA approves Sarclisa regimen for adults with advanced multiple myeloma

March 2, 2020
The FDA approved isatuximab-irfc in combination with pomalidomide and dexamethasone for the treatment of adults with multiple myeloma who received at…
Cover Story

Multiple Myeloma:The Next Frontier for Cell Therapy

Cell Therapy Next, February
The development of chimeric antigen receptor T-cell therapies for multiple myeloma was one of the hottest topics at ASH Annual Meeting and…
Meeting NewsPerspective

Novel small-molecule inhibitor ‘quite promising’ in advanced kidney cancer

February 18, 2020
MK-6482 appeared well-tolerated and showed promising single-agent activity among heavily pretreated patients with clear cell renal cell carcinoma…

Foundation presents grants to six early career cancer researchers

February 9, 2020
The Mark Foundation for Cancer Research presented grants to six early career scientists who are conducting research projects designed to address…

Many US women eligible for breast-conserving therapy still opt for mastectomy

February 4, 2020
Breast-conserving therapy, also known as lumpectomy, followed by radiation has been shown to be as effective as mastectomy for most women with breast…
Meeting NewsPerspective

Blood test could lead to earlier detection of gastrointestinal cancers

January 24, 2020
An investigational blood-based assay demonstrated efficacy in detecting multiple types of cancer, including gastrointestinal cancers, at various…

Will liquid biopsies be used routinely to screen for cancer?

HemOnc Today, January 25, 2020
POINT Genomic analysis of plasma cfDNA has been adopted widely in the care of patients with cancer. Indeed, the rapid and widespread adoption is striking…

Minority patients value, but are less likely to see, oncologists who understand their culture

January 8, 2020
The existence of racial

AACR-MPM Oncology Charitable Foundation awards grants to cancer researchers

January 2, 2020
American Association for Cancer Research and MPM Capital awarded two grants that will provide a combined $800,000 for cancer research. These are the…

ASH presents Scholar Awards to fellows, junior faculty

December 22, 2019
ASH announced the recipients of its 2019 Scholar Awards. The awards — presented to hematologists in the United States and Canada who conduct…
Meeting News

Melflufen, dexamethasone demonstrate long-term OS benefits in multiple myeloma

December 13, 2019
ORLANDO — Treatment with melflufen and dexamethasone led to sustained long-term overall survival among patients with relapsed/refractory…
Meeting NewsPerspective

Ado-trastuzumab emtansine extends DFS in early-stage HER2-positive breast cancer

December 12, 2019
SAN ANTONIO — Ado-trastuzumab emtansine extended DFS compared with paclitaxel plus trastuzumab among patients with early-stage HER2-positive…
Meeting NewsPerspective

Antibody-drug conjugate provides ‘unprecedented’ benefit in metastatic HER2-positive breast cancer

December 11, 2019
SAN ANTONIO — Trastuzumab deruxtecan conferred durable benefit to women with heavily pretreated HER2-posiive metastatic breast cancer…
Meeting News

Allogeneic HSCT after PD-1 therapy safe, effective in Hodgkin lymphoma

December 9, 2019
ORLANDO — Allogeneic hematopoietic stem cell transplantation appeared effective and generally safe for patients with relapsed or refractory…
Meeting News

ASH acknowledges three Choosing Wisely Champions for their ‘elegant, implementable strategies’

December 9, 2019
ORLANDO — ASH named three Choosing Wisely Champions today at its Annual Meeting and Exposition, recognizing clinicians who have implemented…
Meeting News

Daratumumab regimen increases response in transplant-eligible multiple myeloma

December 9, 2019
ORLANDO — The addition of daratumumab to lenalidomide, bortezomib and dexamethasone significantly improved rates of stringent clinical response…